Titan Pharmaceuticals Inc (TTNP)

Add to Watchlists
Create an Alert
1.42 -0.04  -2.74% NASDAQ May 22, 20:00 Delayed 2m USD
View Full Chart
TTNP Price Chart
View All Events

TTNP Events

Date Type Description
01/25/2019 Splits Ratio: 1666667:10000000
View All Performance Charts

TTNP Total Returns Comparison


TTNP One Page Reports



  • URL: https://www.titanpharm.com
  • Investor Relations URL: N/A
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: N/A
  • Last Earnings Release: Nov. 09, 2017
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Titan Pharmaceuticals Inc is a specialty pharmaceutical company. It is engaged in the development of pharmaceutical products. Its product pipeline consists of Probuphine for Opioid addiction, Ropinirole for Parkinson's disease, Triiodothyronine (T3) for hypothyroidism. It generates revenue principally from collaborative research and development arrangements, technology licenses, and government grants.

TTNP Comparables


Excel Add-In Codes

  • Name: =YCI("TTNP","name")
  • Description: =YCI("TTNP","description")
  • Sector: =YCI("TTNP","sector")
  • Industry: =YCI("TTNP","industry")
  • Est. Current Fiscal Year End: =YCI("TTNP","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.